News

08.16.11 | Jessica Baker Flechtner, VP of Research, will present at the Immunotherapeutics and Vaccine Summit, August 17, 2011 in Cambridge, MA

02.16.11 | Results from Genocea Pneumococcus Vaccine Collaboration with Children’s Hospital of Boston and PATH Published in Cell Host & Microbe.

02.01.11 | Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer

01.03.11 | Genocea Biosciences Closes $35 Million Series B Financing

08.12.10 | Genocea Biosciences Hires Chip Clark as Chief Business Officer

07.19.10 | Wall Street Journal: Two Start-Ups Aim to Change Economics of Vaccine Production

06.10.10 | Drug Development Technology: The Race for a Malaria Vaccine

04.15.10 | Genocea Biosciences Enters Into Cooperative Research and Development Agreement with U.S. Military to Develop Malaria Vaccine

03.18.10 | Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens

02.13.10 | Genocea Biosciences Licenses Extensive Herpes Simplex Virus Patent Estate from the University of Washington

01.28.10 | Genocea Biosciences Appoints Paul Giannasca Vice President of Development

12.15.09 | Genocea Biosciences Awarded Grant for the Development of Chlamydia Vaccines from the University of Pittsburgh Medical Center's Sexually Transmitted Infections Cooperative Research Center

11.23.09 | Genocea Biosciences Expands Scientific Advisory Board with Appointment of Four Vaccine Experts

11.13.09 | BusinessWeek Names Genocea One of World's Most Intriguing Startups

07.27.09 | John Sorvillo joins Genocea as Vice President of Business Development

07.21.09 | FOXBusiness Video: Interview with Genocea CEO Staph Bakali and Scientific Founder Darren Higgins

07.21.09 | FOXBusiness: Q&A with Genocea CEO Staph Bakali

06.19.09 | Bob Farrell joins Genocea as Vice President of Finance & Administration

06.14.09 | Genocea in The Boston Globe - Where the Jobs Are In Anxious Times

03.09.09 | Forbes: Creating New, Innovative Vaccines

02.19.09 | Genocea Closes $23M Series A Financing; Appoints Staph Bakali CEO

02.11.09 | Jane Halpern joins Genocea as Vice President of Regulatory Affairs

11.03.08 | Genocea featured in Genetic Engineering News magazine

07.23.08 | Staph Bakali joins Genocea's Board of Directors

06.24.08 | Genocea Selected as one of top 15 biotech companies of 2008

06.05.08 | Genocea, PATH and Children's Hospital Boston partner to develop pneumococcal vaccine

04.23.08 | Genocea Wins "Best Vaccine Startup" at World Vaccine Congress

03.15.08 | Darren Higgins featured on cover of Human Vaccines magazine

12.27.07 | Genocea featured in Forbes story on "Next Generation Vaccines"

12.18.07 | Genocea licenses portfolio of vaccine targets from Harvard Medical School

08.21.07 | Genocea appoints Adel Mahmoud and Robert Finberg to Scientific Advisory Board

06.20.07 | Vaccine expert George Siber joins Genocea Biosciences as Executive Chairman

05.16.07 | Genocea featured in The New York Times - Warding Off Diseases, Many Vaccines at a Time

03.19.07 | Ian Gust, Former Director of Research & Development at CSL Ltd, joins Genocea's Scientific Advisory Board

02.23.07 | Genocea featured in Mass High Tech article - Harvard Heavy Hitters Launch New Venture

12.22.06 | Genocea raises initial funding from Lux Capital & Polaris Venture Partners

03.20.06 | Higgins' research featured in Harvard Medical School Press Release - Novel Vaccine Approach Stimulates Protective Immunity Against Listeria

03.01.06 | Darren Higgins profiled in Harvard Magazine

08.15.05 | Darren Higgins featured in The Boston Globe